Uncorrected refractive error in the African American eye disease study

JAMA Ophthalmology

2024-02-22

(Press-News.org) About The Study: The results of this study suggest a high burden of refractive error–associated correctable refractive error in African American adults, making it the leading cause of visual impairment in this population. Providing universal coverage for vision care and prescription glasses is an affordable and achievable health care intervention that could reduce the burden of visual impairment in African American adults by over two-thirds and likely raise the quality of life and work productivity, especially in this vulnerable minority population.

Authors: Rohit Varma, M.D., M.P.H., of the CHA Hollywood Presbyterian Medical Center in Los Angeles, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaophthalmol.2023.6781)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2023.6781?guestAccessKey=0797fd1d-8e5e-4d5c-9318-5a4ddf843632&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022224

END

ELSE PRESS RELEASES FROM THIS DATE:

Vision impairment and psychosocial function in older adults

2024-02-22

About The Study: Vision impairment was associated with several psychosocial outcomes, including symptoms of depression and anxiety and social isolation in this study including 2,822 U.S. adults age 65 and older. These findings provide evidence to support prioritizing research aimed at enhancing the health and inclusion of people with vision impairment. Authors: Pradeep Y. Ramulu, M.D., M.H.S., Ph.D., of the Johns Hopkins University School of Medicine in Baltimore, is the corresponding author. To access the embargoed ...

Chronic stress spreads cancer … here’s how

2024-02-22

Stress is inevitable. But too much of it can be terrible for our health. Chronic stress can increase our risk for heart disease and strokes. It may also help cancer spread. How this works has remained a mystery—a challenge for cancer care. Xue-Yan He, a former postdoc in Cold Spring Harbor Laboratory (CSHL) Adjunct Professor Mikala Egeblad’s lab, says, “Stress is something we cannot really avoid in cancer patients. You can imagine if you are diagnosed, you cannot stop thinking about the disease or insurance ...

Markey study reveals extent of undiagnosed cancer cases due to COVID-19 pandemic

2024-02-22

Over 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to a new University of Kentucky Markey Cancer Center study. The report published in JAMA Oncology Feb. 22 provides the first estimates of missed cancer diagnoses in 2020 using nationwide surveillance data. Researchers have expected impacts to cancer detection as a result of delayed screenings and missed health care appointments due to the COVID-19 pandemic, but the extent of this impact had not been quantified until ...

NextGen Precision Health researchers uncover potential treatment for cardiovascular complications from type 2 diabetes

2024-02-22

New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes. More than 30 million Americans live with Type 2 diabetes. One common feature of diabetes is the hardening and inflexibility of blood vessels caused by damage to the endothelial cells in the vascular system. Over time, this can lead to the development and progression of cardiovascular disease, which is the number one cause of death in diabetics. Because endothelial dysfunction is causally linked to cardiovascular disease, there is a considerable ...

Immune cell receptor provides promising immunotherapy target

2024-02-22

FOR IMMEDIATE RELEASE Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients’ immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. The study, published online Jan. 8 in Oncoimmunology, identifies a new strategy cancer cells use to protect themselves from immune system attack, and suggests treatments that could counteract it. It shows that tumor cells and some immune cells produce proteins called activins that ...

Silicon microresonators for artificial neural networks

2024-02-22

Researchers have made significant progress in the development of artificial neural networks using tiny silicon devices called microresonators, paving the way for faster and more energy-efficient artificial intelligence systems. These networks mimic the computing capabilities of the human brain, breaking away from traditional digital computer architectures and leveraging the speed, low power dissipation and multi-wavelength capabilities of photonics. A review article describing the implementations of neural networks using silicon microresonators was published Jan. 16 in Intelligent Computing, a Science Partner Journal. Silicon microresonators ...

Scientists develop a simple blood test to quickly diagnose sarcoidosis

2024-02-22

Scientists develop a simple blood test to quickly diagnose sarcoidosis NIH-funded tool can accurately identify the potentially life-threatening inflammatory disease A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs in the body. The tool, which uses a simple blood test, could allow for selective use of more invasive diagnostic tests often used to identify the ...

New electrochemical system enables efficient metal recovery from industrial wastewater

2024-02-22

A research team at Tsinghua University led by Professor Huijuan Liu has developed a new electrochemical system that promises to revolutionize metal recovery from industrial wastewater. The research was published in Engineering. Industrial wastewater poses significant environmental hazards due to heavy metal pollution. Current methods for metal recovery, such as electrodeposition, suffer from interfacial ion transport limitations, resulting in slow and low-quality recovery. In their study, the team proposed a novel approach that integrates a transient electric field (TE) and swirling flow (SF) to improve mass transfer and promote interfacial ...

Non-solvating electrolytes enhance performance of organic electrode-based batteries

2024-02-22

In a groundbreaking study, Professor Won-Jin Kwak in the School of Energy and Chemical Engineering at UNIST, in collaboration with researchers from Hanyang University, have pioneered a method to significantly enhance the performance and lifespan of organic electrode-based batteries. The findings promise to accelerate the commercialization of eco-friendly batteries and pave the way for further advancements in the field. Organic electrodes have long been recognized for their cost-effectiveness and natural abundance, making them a promising alternative to traditional lithium-ion battery ...

NIFTY® DNBSEQ-G99 platform receives CE-IVDD certification and advances prenatal care standards

2024-02-22

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD certification to include the DNBSEQ-G99 model to meet the European Union regulations for medical devices. In January 2024, BGI Genomics unveiled the NIFTY® ultra-fast non-invasive prenatal genetic testing product, utilizing the innovative DNBSEQ-G99 platform. Designed for both small and medium throughput, this platform ensures top-notch testing ...

Uncorrected refractive error in the African American eye disease study

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: